City of Hope: Anti-Tumor Drug AMG 510 Shows Promise in Phase 1 Trial
September 23, 2020
September 23, 2020
DUARTE, California, Sept. 23 (TNSJou) -- City of Hope issued the following news release on Sept. 22:
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other comprehensive cancer centers.
The multisite clinical trial included 129 metastatic cancer patients who had received an average of thre . . .
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other comprehensive cancer centers.
The multisite clinical trial included 129 metastatic cancer patients who had received an average of thre . . .